SCLC tumors in this model represent the predominant subtype of SCLC, characterized by expression of neuroendocrine markers and high levels of the transcription factor ASCL1 (“SCLC‐A” subtype) (Rudin et al, 2019). This evidence concerns the gene ASCL1 and small cell lung carcinoma.